Concepedia

Tae Sung

TS

7

Publications

419

Citations

7

H-Index

2015

Active since

Affiliations

Pfizer (United States)(Current)

Tae Sung is an author at Pfizer (United States) specializing in medicine, pharmacology, and autophagy.

Top concepts

Publications per year

2015–2025

7

Publications

7

Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies

Wenyue Hu, Tae Sung, Bart Jessen et al. · Clinical Cancer Research · 2015 · 163 citations

Lysosomal adaptation: How cells respond to lysosomotropic compounds

Shuyan Lu, Tae Sung, Nianwei Lin et al. · PLoS ONE · 2017 · 154 citations · Full text

, , +17

CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety

Cynthia L. Palmer, Britton Boras, Bernadette Pascual et al. · Cancer Cell · 2025 · 35 citations · Full text

Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology

Stéphane Thibault, Wenyue Hu, Brad Hirakawa et al. · Molecular Cancer Therapeutics · 2018 · 29 citations

A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor

Wenbo Chen, Britton Boras, Tae Sung et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2020 · 13 citations · Full text

, , +12

Rows per page

1–5 of 7